Mannose-binding lectin 2 and myosin light chain kinase 2, a serine/threonine kinase, were identified as potential biomarkers for the pancreatic cancer diagnosis and further validated by western blot in an independent set of sera from pancreatic cancer patients and normal controls. This evidence concerns the gene MYLK2 and familial pancreatic carcinoma.